Alexander M. Menzies
The University of Sydney(AU)University of Sydney(AU)Mater Health Services(AU)Royal North Shore Hospital(AU)Royal North Shore Hospital(AU)Melanoma Institute Australia(AU)Northern Sydney Local Health District(AU)Westmead Institute for Medical Research(AU)Mater Hospital(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors(2018)2,518 cited
- → Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy(2016)1,160 cited
- → Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma(2011)1,037 cited
- → Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy(2019)1,004 cited
- → Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study(2018)982 cited
- → Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab(2016)814 cited